Anemia of Prematurity-Do we know enough

Brown Phibbs RH , Garcia JF. Dallman PR. Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurity. J Pediatr 1984;. 105: 793–798.

Owen P. Smith , Ian Malcolm Hann , Robert J Areci , Pediatric Hematology, 3rd Edition; 144–146

Ohls RK : Developmental erythropoiesis. In: Polin RA , Fox WW , eds. Fetal and Neonatal Physiology. Vol 2. 2nd ed. Philadelphia, Pa: WB Saunders Co: 1762–1786

Spitzer Alan (2005) intensive care of the fetus & neonate. Elsevier, 1286. ISBN 1-56053-512-1

Pathak A , Roth P , Piscitelli J Johnson . Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity. Arch. Dis. Child. Fetal Neonatal Ed. 2003;88:F324–328

Kirpalani H , Whyte RK , Andersen C , et al: The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006;149:301–307

Voak D , Chapman J , Finney RD , . BCSH Blood Transfusion Task Force: Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfusion Med 1996; 6:261–271.

Akahoshi M , Takanashi M , Masuda M , . A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992;32:169–172.

Linden JV , Pisciotto PT. Transfusion-associated graft-versus-host disease and blood irradiation. Transfusion Med Rev 1992;6:116–123.

Bowden RA , Slichter SJ , Sayers M , et al: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant Blood 1995;86:3598–3603

Schwarz KB , Dear PR , Gill AB , et al: Effects of transfusion in anemia of prematurity. Pediatr Hematol Oncol 2005;22:551–559

Nazir S. , Peverini R. L , Deming D. D. , Hopper A. O. , Vyhmeister N. R. . Comparison of 2 Iron Doses in Infants Receiving Recombinant Human Erythropoietin Therapy. Arch Pediatr Adolesc Med 2002;156: 540–544

Vamvakas EC , Strauss RG : Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001; 41: 406–415

Ohls R. K. , Ehrenkranz R. A. , Wright L L , Lemons J. A. , Korones S. B. , Stoll B. J. , Stark A. R. , Shankaran S. , Donovan E. F. , Close N. C , Das A. , for the National Institute of Child Health and Hum. Effects of Early Erythropoietin Therapy on the Transfusion Requirements of Preterm Infants Below 1250 Grams Birth Weight: A Multicenter, Randomized, Controlled Trial. Pediatrics 2001;108: 934–942

Donato H. , Vain N. , Rendo P. , Vivas N. , Prudent L. , Larguía M. , Digregorio J. , Vecchiarelli C , Valverde R. , García C , Subotovsky P. , Solana C , Gorenstein A. , for the Private Hospitals Neonatal Network. Effect of Early Versus Late Administration of Human Recombinant Erythropoietin on Transfusion Requirements in Premature Infants: Results of a Randomized, Placebo-Controlled, Multicenter Trial. Pediatrics 200;105: 1066–1072